Phase I trial of a novel hTERT vaccination strategy addressing T effector cells and immune-suppressor mechanisms

J. Spicer, V. Kwatra, C. Verma, K. Ioannou, R. Goldstein, T. Brier, J. Eremin, N. Zareian, L. Walker, D. Lobo, F. Farzaneh, O. Eremin

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)viii412
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
Publication statusPublished - 1 Oct 2018

Cite this